0 Bewertungen
ID

20229

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Stichworte

Versionen (2)
  1. 15.02.17 15.02.17 -
  2. 20.02.17 20.02.17 -
Hochgeladen am

15. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Englisch

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulare  
    Toast Criteria
    Beschreibung

    Toast Criteria

    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    Beschreibung

    Etiologic subtype

    Datentyp

    integer

    Concomitant Medication
    Beschreibung

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    2. Are any medications listed below currently being taken on the day of visit 1?
    Beschreibung

    Medication taken

    Datentyp

    boolean

    If yes, please indicate which, if any, of the following are currently being taken:
    Beschreibung

    If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

    Datentyp

    integer

    ACE Inhibitors
    Beschreibung

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015
    3. Are ACE Inhibitors currently being taken on the day of visit 1?
    Beschreibung

    ACE Inhibitors currently taken

    Datentyp

    boolean

    Name of ACE Inhibitor and Total Daily Dose
    Beschreibung

    Name of ACE Inhibitor and Total Daily Dose

    Datentyp

    text

    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Toast Criteria
    Item
    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    integer
    Etiologic subtype
    Code List
    1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
    CL Item
    Large-artery atherosclerosis (1)
    CL Item
    Cardioembolism (2)
    CL Item
    Small-artery occlusion (lacune) (3)
    CL Item
    Acute stroke of other determined etiology (4)
    CL Item
    Stroke of underdetermined etiology (5)
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Medication taken
    Item
    2. Are any medications listed below currently being taken on the day of visit 1?
    boolean
    Item
    If yes, please indicate which, if any, of the following are currently being taken:
    integer
    If yes, please indicate which
    Code List
    If yes, please indicate which, if any, of the following are currently being taken:
    CL Item
    Dipyridamole (0)
    CL Item
    Aspirin (1)
    CL Item
    Ticlopidine (2)
    CL Item
    Clopidogrel (3)
    CL Item
    Aspirin/extended release Dipyridamole (4)
    CL Item
    Oral anticoagulants (5)
    CL Item
    Nitrates (oral or topical) (6)
    CL Item
    Estrogen replacement without progesterone (7)
    CL Item
    Estrogen replacement with progesterone (8)
    CL Item
    Digitalis (9)
    CL Item
    Statins (10)
    CL Item
    Fibrates (11)
    CL Item
    Dilitazem/Verapamil (12)
    CL Item
    Other calcium channel blockers (13)
    CL Item
    Alpha-blocker (14)
    CL Item
    Direct vasodilators (15)
    CL Item
    Angiotensin Receptor Blocker (ARB) (16)
    CL Item
    Peripheral sympatholytic (17)
    CL Item
    Central sympatholytic (18)
    CL Item
    Alpha-beta blocker (19)
    CL Item
    Beta-blocker (20)
    CL Item
    Loop-active diuretics (21)
    CL Item
    Diuretics of thiazide type (22)
    CL Item
    Potassium-sparing diuretics (23)
    CL Item
    Insulin (24)
    CL Item
    Oral hypoglycemic agents (25)
    CL Item
    Non-steroidal anti-inflammatory drugs (26)
    CL Item
    Specific Cox II inhibitors (27)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    3. Are ACE Inhibitors currently being taken on the day of visit 1?
    boolean
    Name of ACE Inhibitor and Total Daily Dose
    Item
    Name of ACE Inhibitor and Total Daily Dose
    text
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video